Status:
COMPLETED
The VERIFY Study: An Observational Study Called VERIFY to Learn More About the Use of Vericiguat in People With Chronic Heart Failure With Reduced Ejection Fraction
Lead Sponsor:
Bayer
Conditions:
Chronic Heart Failure With Reduced Ejection Fraction
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study in which the health data of people with chronic heart failure with reduced ejection fraction (HFrEF) are collected using administrative claims data. In observational st...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- ≥18-years old and have at least one year of continous enrollment in the HV database.
- Have proven or presumed HFrEF
- Have received ≥1 GDMTs for HFrEF
- All patients will be required to have continuous enrollment in the HealthVerity data set during the pre-index date (baseline period) of at least 90-days.
Exclusion
Key Trial Info
Start Date :
July 11 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 8 2024
Estimated Enrollment :
1391 Patients enrolled
Trial Details
Trial ID
NCT05974189
Start Date
July 11 2023
End Date
October 8 2024
Last Update
November 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bayer
Berlin, Germany, 13342